If you work in oncology or infusion, you already know that biosimilars aren't coming; they're here. For most drugs, your team has figured out the clinical piece. You know the science, you understand interchangeability, and you've read the FDA approvals.

The part that keeps tripping people up isn't clinical. It's communication.

And like I said at the Health Connect Partners event in May (to a room full of chuckles), formulary excites me. 😀 If you don’t believe me, here’s proof...

Audit Demonstrates Rpharmy's Dedication to Protecting Sensitive Customer Data

Austin-Based Healthcare Technology Provider Recognized for Community Impact, Life-Saving Solutions that Protect Patients, Healthcare Workers

Austin-Based Healthcare Technology Provider on a Mission to Protect Patients from Medication Safety Errors, Healthcare Workers from Hazardous Drug Exposure 

Annual Feature Highlights Leaders Instrumental in Protecting Patients from Risks, Including Preventable Medication Errors, Like Rpharmy 

Cloud-Based USP <800> Compliance, Hazardous Drugs Platform Honored for Innovation in Healthcare Worker Protection

Rhazdrugs Client, Medication Safety Officer to Share Real-World Use of Rhazdrugs in USP <800> Compliance, Worker Safety

Annual List Celebrates Innovative Women in Health IT Who Are Committed to Improving Healthcare Through Technology

Rpharmy Client, Medication Safety Officer to Host Lunch and Learn Event Focused on How Scripps Health Uses Rhazdrugs to Protect Healthcare Workers From Hazardous Drugs Exposure